Verne Bioanalytics

Verne Bioanalytics, operating as Verne Bio, is a biotechnology company founded in 2020 that specializes in rapid, scalable genetic and pathogen testing for the cannabis, hemp, and wine industries. The company utilizes a proprietary integration of bioinformatics, AI, and wet-lab expertise to provide proactive plant health management. Their core offerings include the i-Test, a user-administered on-site testing kit, and the We-Test, a mail-in diagnostic service, both designed to identify pathogens, verify genetic markers, and enable crop steering. By leveraging AI-driven data analysis, Verne Bio can simultaneously test for numerous targets with high precision, offering a more efficient alternative to conventional diagnostic methods.

These solutions address critical operational challenges for cultivators, such as preventing catastrophic crop loss from diseases like Hop Latent Viroid (HpLVd) and improving overall yield and productivity. By functioning as a fractional partner in plant health management, Verne Bio helps growers reduce labor, mitigate financial risk, and implement proactive remediation strategies. Their services have been utilized by hundreds of customers to optimize cultivation environments, with clients reporting significant improvements in output and substantial reductions in losses due to plant pathogens. The company is actively expanding its reach, providing consulting services and exploring the licensing of its technology for international use.